Inactive Instrument

Highlights Wound Management Technologies Inc Other OTC

Equities

US98211X1063

Highlights

Unlock all the news: Be the first to know and act before the market!

Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down	05-13	MT
Sanara MedTech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Earnings Flash (SMTI) SANARA MEDTECH Posts Q4 Revenue $17.7M, vs. Street Est of $16.5M	03-25	MT
Sanara MedTech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-25	CI
Sanara MedTech Reports Higher Preliminary Q4 Revenue	02-22	MT
Sanara MedTech Secures Exclusive Licensing Deal with Tufts University for 18 Collagen Peptides	01-03	MT
Sanara MedTech Q3 Loss Narrows, Revenue Rises; Shares Fall After Hours	11-13	MT
Earnings Flash (SMTI) SANARA MEDTECH Reports Q3 Revenue $16M, vs. Street Est of $18.8M	11-13	MT
Sanara MedTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Sanara MedTech Inc. Announces BIASURGE Advanced Surgical Solution Updates	23-10-10	CI
Earnings Flash (SMTI) SANARA MEDTECH Reports Q2 Revenue $15.8M, vs. Street Est of $16.9M	23-08-14	MT
Sanara MedTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Sanara MedTech Inc. acquired Certain Assets Related to its Collagen Products Business from Applied Nutritionals, LLC, The Hymed Group Corporation, and Dr. George Petito for 25.3 million.	23-08-01	CI
Sanara MedTech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Sanara MedTech Says it Received 510(k) Clearance for Biasurge Surgical Product	23-04-04	MT
Sanara MedTech Reports Rising Preliminary Q4 Revenue	23-02-22	MT
Sanara MedTech Inc. Provides Preliminary Earnings Guidance for the Fourth Quarter and Full-Year 2022	23-02-22	CI
Sanara MedTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Sanara MedTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Sanara MedTech Completes Acquisition of Scendia Biologics for $7.4 Million	22-07-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Wound Management Technologies Inc Other OTC

Equities

US98211X1063

Highlights

Filters